Profound Medical Corp. (PROF)
NASDAQ·Healthcare·Medical - Devices
$6.69
-0.89%
Mkt Cap $158.26M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $7.67M | $5.98M | -22.04% | -$0.27 | -$0.27 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | $10.53M | $5.23M | -50.31% | -$0.38 | -$0.26 | +31.58% | — | — |
| Q3 2025 Aug 14, 2025 | $4.73M | $2.21M | -53.29% | -$0.43 | -$0.52 | -20.93% | — | — |
| Q2 2025 May 8, 2025 | $4.69M | $2.62M | -44.12% | -$0.29 | -$0.36 | -24.14% | — | — |
| Q1 2025 Mar 6, 2025 | $5.92M | $5.33M | -9.99% | -$0.31 | -$0.20 | +35.48% | — | — |
| Q4 2024 Nov 7, 2024 | $5.92M | $3.83M | -35.36% | -$0.30 | -$0.38 | -26.67% | — | — |
| Q3 2024 Aug 8, 2024 | $2.59M | $2.23M | -13.80% | -$0.29 | -$0.28 | +3.45% | — | — |
| Q2 2024 May 9, 2024 | $2.52M | $1.44M | -42.90% | -$0.30 | -$0.26 | +13.33% | — | — |
| Q1 2024 Mar 7, 2024 | $1.95M | $2.66M | +36.51% | -$0.32 | -$0.42 | -31.25% | — | — |
| Q4 2023 Nov 2, 2023 | $2.02M | $1.73M | -14.46% | -$0.33 | -$0.26 | +21.21% | — | — |
| Q3 2023 Aug 9, 2023 | $2.17M | $1.60M | -26.18% | -$0.34 | -$0.35 | -2.94% | — | — |
| Q2 2023 May 10, 2023 | $2.11M | $1.86M | -11.84% | -$0.34 | -$0.32 | +5.88% | — | — |
| Q1 2023 Mar 7, 2023 | $2.67M | $1.70M | -36.32% | -$0.36 | -$0.46 | -27.78% | — | — |
| Q4 2022 Nov 3, 2022 | $2.41M | $2.81M | +16.42% | -$0.38 | -$0.24 | +36.84% | — | — |
| Q3 2022 Aug 4, 2022 | $2.02M | $2.01M | -0.40% | -$0.40 | -$0.28 | +30.00% | — | — |
| Q2 2022 May 9, 2022 | $1.76M | $1.71M | -2.90% | -$0.43 | -$0.40 | +6.98% | — | — |
| Q1 2022 Mar 3, 2022 | $2.79M | $1.26M | -54.76% | -$0.37 | -$0.49 | -32.43% | — | — |
| Q4 2021 Nov 4, 2021 | $2.24M | $3.21M | +43.20% | -$0.28 | -$0.29 | -3.57% | — | — |
| Q3 2021 Aug 4, 2021 | $2.58M | $2.60M | +1.10% | -$0.28 | -$0.35 | -25.00% | — | — |
| Q2 2021 May 12, 2021 | $671.50K | $893.60K | +33.08% | -$0.27 | -$0.37 | -37.04% | — | — |